AACR Award for Lifetime Achievement in Cancer Research will be presented to Rakesh K. Jain, PhD, Fellow of the AACR Academy, during the AACR Annual Meeting 2025, to be held April 25-30 at the ...

The following is a summary of "Controversial Role Of Cd151 In Different Solid Tumors: Promoter Or Suppressor?,” published in ...

Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one ...

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...

Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET. Company Participants. Douglas Onsi - President ...

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with a high unmet medical need, today announced two important ...

Seoul, South Korea Saturday, March 29, 2025, 14:00 Hrs [IST] ...

Is this growing wellness trend the holy grail of holistic health remedies, or is it a scam? I took a deep dive to find out.

Roles of different types of RNAs including lncRNAs, miRNAs and circular RNAs,..in cancer promotion, development, invation, angiogenesis and metastasis,... Articles that are accepted for publication by ...

XBiotech Inc. (NASDAQ:XBIT – Get Free Report) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 800,100 ...